Related Experiment Videos

Depression and pharmacogenetics: A psychiatric pharmacist's perspective

Ian R McGrane¹, Shannon Mertens¹

¹College of Health Professions & Biomedical Sciences, The University of Montana, 328 Skaggs Building, 32 Campus Drive, Missoula, MT 59812, USA.

Archives of Psychiatric Nursing

|May 23, 2018

Summary

No abstract available in PubMed .

Keywords:

Depression MTHFR Methylenetetrahydrofolate reductase Pharmacogenetics l-Methylfolate

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.

Journal of clinical psychopharmacology·2025

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.

Journal of clinical psychopharmacology·2025

Med rec double check: Inpatient psychiatry medication errors identified on admission using Medicaid Web portals and electronic pharmaceutical claims data.

The mental health clinician·2024

Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.

Journal of clinical psychopharmacology·2023

Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies.

Journal of forensic sciences·2022

Possible inhibitory effects of terbinafine on aripiprazole metabolism: Two case reports.

The mental health clinician·2021

See all related articles